GlassScriptPhysician profile
John J Peet
NPI 1477641322
$5,063.37
in general payments reported to CMS, 2019-2025
30 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $1,264 · 2021: $1,019 · 2022: $1,114 · 2023: $453 · 2024: $436 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,488.00 | 2019-2021 | |
| Allergan, INC. | $947.06 | 2019-2022 | |
| Abbvie INC. | $731.12 | 2019-2024 | |
| Revance Therapeutics, INC. | $357.51 | 2024-2025 | Daxxify |
| Mayne Pharma Commercial LLC | $272.99 | 2021-2024 | |
| Galderma Laboratories, L.P. | $254.59 | 2021-2025 | Dysport |
| Astellas Pharma US INC | $194.19 | 2020-2025 | Veozah |
| Myovant Sciences INC. | $112.35 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $102.16 | 2019-2020 | |
| Avion Pharmaceuticals | $67.39 | 2019-2023 | NP Thyroid 60 |
| Vertical Pharmaceuticals, LLC | $58.57 | 2019-2020 | |
| Hologic Sales and Service, LLC | $55.39 | 2025 | Aptima, Thinprep 2000 Processor |
| Ascend Therapeutics US, LLC | $48.03 | 2019-2023 | |
| Exact Sciences Corporation | $46.54 | 2023-2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $37.94 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $35.43 | 2019-2021 | |
| Ethicon US, LLC | $26.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.11 | 2019-2020 | |
| Acella Pharmaceuticals, LLC | $23.70 | 2025 | NP Thyroid 60 |
| Millicent US INC | $18.84 | 2019 | |
| Dexcom, INC. | $18.48 | 2025 | Dexcom G6 Transmitter |
| Meditrina | $18.47 | 2020 | |
| Evofem Biosciences, INC. | $17.78 | 2020 | |
| Currax Pharmaceuticals LLC | $16.34 | 2021 | |
| Vivus LLC | $15.95 | 2022 | |
| Novo Nordisk INC | $15.77 | 2020 | |
| Acessa Health INC. | $14.90 | 2020 | |
| Renovia INC | $14.82 | 2019 | |
| Minerva Surgical, INC | $13.53 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Peet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.